Moderna won’t enforce COVID-19 patents
siam.pukkato / Shutterstock.com
A US Department of Health and Human Services agency will investigate whether biopharmaceutical company, Moderna Therapeutics, fully disclosed information on government funding in patent applications relating to its COVID-19 vaccine candidate and its work on a Zika vaccine.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Moderna, COVID-19, Zika, patent, applications, BARDA, DARPA, Knowledge Ecology international, USPTO